<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39444292</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2060</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Annals of medicine</Title><ISOAbbreviation>Ann Med</ISOAbbreviation></Journal><ArticleTitle>Study on the predictive value of laboratory inflammatory markers and blood count-derived inflammatory markers for disease severity and prognosis in COVID-19 patients: a study conducted at a university-affiliated infectious disease hospital.</ArticleTitle><Pagination><StartPage>2415401</StartPage><MedlinePgn>2415401</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2415401</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/07853890.2024.2415401</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Since the outbreak of coronavirus disease 2019 (COVID-19), studies have found correlations between blood cell count-derived inflammatory markers (BCDIMs) and disease severity and prognosis in COVID-19 patients. However, there is currently a lack of systematic comparisons between procalcitonin (PCT), C-reactive protein (CRP), C-reactive protein-to-albumin ratio (CAR) and BCDIMs for assessing the severity and prognosis of COVID-19 patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A total of 1040 COVID-19 patients were included in the study. Demographics, comorbidities and laboratory results were analysed. BCDIMs refer to the following ratios: neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-C-reactive protein ratio (LCR), systemic inflammation response index (SIRI) and systemic inflammation index (SII). Disease severity and 28-day mortality are clinical outcomes of this study. Area under the curve (AUC) of receiver operating characteristic (ROC) curve was calculated for these markers, and DeLong's test compared their statistical differences. Cox regression analysis assessed their predictive value for the 28-day mortality rate.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Among the 1040 patients, 35.3% were severe/critical, 49.6% were moderate and 15.1% were mild cases. Within 28 days, 15.1% died. The NLR had the highest predictive value for disease severity (AUC: 0.790, 95% CI: 0.762-0.818). NLR differed significantly from other markers, except LCR. LCR best predicted 28-day mortality (AUC: 0.798, 95% CI: 0.766-0.829). Some markers showed significant differences in AUC with LCR. Multivariable Cox regression identified BCDIMs, PCT, CRP and CAR as significant risk factors for 28-day mortality.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">PCT, CRP, CAR and BCDIMs, easily obtained in clinical settings, are valuable predictors of disease severity and the 28-day mortality in COVID-19 patients. The NLR is particularly effective for disease severity, while the LCR is highly predictive of 28-day mortality. These markers provide guidance for stratified management of COVID-19 patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Zhipeng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Beijing Youan Hospital, Capital Medical University, Beijing, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Research Center for Respiratory Infectious Diseases, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Beijing Youan Hospital, Capital Medical University, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Beijing Youan Hospital, Capital Medical University, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geng</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Beijing Youan Hospital, Capital Medical University, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Beijing Youan Hospital, Capital Medical University, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yueke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Beijing Youan Hospital, Capital Medical University, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Hongbo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Engineering Research Center for Precision Medicine and Transformation of Hepatitis and Liver Cancer, Beijing Youan Hospital, Capital Medical University, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Qingkun</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Beijing Youan Hospital, Capital Medical University, Beijing, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Center of Biobank, Beijing Youan Hospital, Capital Medical University, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Beijing Youan Hospital, Capital Medical University, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yingmin</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-2311-9712</Identifier><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Beijing Youan Hospital, Capital Medical University, Beijing, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Research Center for Respiratory Infectious Diseases, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Med</MedlineTA><NlmUniqueID>8906388</NlmUniqueID><ISSNLinking>0785-3890</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077740">Procalcitonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012709">Serum Albumin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="Y">C-Reactive Protein</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077740" MajorTopicYN="Y">Procalcitonin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="Y">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001772" MajorTopicYN="N">Blood Cell Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012709" MajorTopicYN="N">Serum Albumin</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">28-day mortality</Keyword><Keyword MajorTopicYN="N">BCDIMs</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">disease severity</Keyword><Keyword MajorTopicYN="N">laboratory inflammatory markers</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>16</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>16</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>3</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39444292</ArticleId><ArticleId IdType="pmc">PMC11504162</ArticleId><ArticleId IdType="doi">10.1080/07853890.2024.2415401</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C, Wang Y, Li X, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet . The COVID-19 pandemic in 2023: far from over. Lancet. 2023;401(10371):79.</Citation><ArticleIdList><ArticleId IdType="pubmed">36641201</ArticleId></ArticleIdList></Reference><Reference><Citation>HDR UK COALESCE Consortium . Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales. Lancet. 2024;403(10426):554–566.</Citation><ArticleIdList><ArticleId IdType="pubmed">38237625</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng S, Phillips DJ, White T, et al. . Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nat Med. 2021;27(11):2032–2040. doi: 10.1038/s41591-021-01540-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01540-1</ArticleId><ArticleId IdType="pmc">PMC8604724</ArticleId><ArticleId IdType="pubmed">34588689</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Y, Li X, Zhang L, et al. . SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct Target Ther. 2022;7(1):141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047469</ArticleId><ArticleId IdType="pubmed">35484110</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambichler T, Schuleit N, Susok L, et al. . Prognostic performance of inflammatory biomarkers based on complete blood counts in COVID-19 patients. Viruses. 2023;15(9):1920. doi: 10.3390/v15091920.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15091920</ArticleId><ArticleId IdType="pmc">PMC10536301</ArticleId><ArticleId IdType="pubmed">37766326</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B, Kojima S, Kawamoto A, et al. . COVID-19 pathogenesis, prognostic factors, and treatment strategy: urgent recommendations. J Med Virol. 2021;93(5):2694–2704. doi: 10.1002/jmv.26754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26754</ArticleId><ArticleId IdType="pubmed">33368358</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian W, Jiang W, Yao J, et al. . Predictors of mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis. J Med Virol. 2020;92(10):1875–1883. doi: 10.1002/jmv.26050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26050</ArticleId><ArticleId IdType="pmc">PMC7280666</ArticleId><ArticleId IdType="pubmed">32441789</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan J, Li H, Ma X, et al. . Predicting SARS-CoV-2 infection among hemodialysis patients using multimodal data. Front Nephrol. 2023;3:1179342. doi: 10.3389/fneph.2023.1179342.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneph.2023.1179342</ArticleId><ArticleId IdType="pmc">PMC10479652</ArticleId><ArticleId IdType="pubmed">37675373</ArticleId></ArticleIdList></Reference><Reference><Citation>Acedera ML, Sirichokchatchawan W, Brimson S, et al. . Age, comorbidities, C-reactive protein and procalcitonin as predictors of severity in confirmed COVID-19 patients in the Philippines. Heliyon. 2023;9(4):e15233. doi: 10.1016/j.heliyon.2023.e15233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e15233</ArticleId><ArticleId IdType="pmc">PMC10074734</ArticleId><ArticleId IdType="pubmed">37035364</ArticleId></ArticleIdList></Reference><Reference><Citation>Hippisley-Cox J, Khunti K, Sheikh A, et al. . Risk prediction of covid-19 related death or hospital admission in adults testing positive for SARS-CoV-2 infection during the omicron wave in England (QCOVID4): cohort study. BMJ. 2023;381:e072976. doi: 10.1136/bmj-2022-072976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072976</ArticleId><ArticleId IdType="pmc">PMC10282241</ArticleId><ArticleId IdType="pubmed">37343968</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayah W, Berkane I, Guermache I, et al. . Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19. Cytokine. 2021;141:155428. doi: 10.1016/j.cyto.2021.155428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2021.155428</ArticleId><ArticleId IdType="pmc">PMC7834734</ArticleId><ArticleId IdType="pubmed">33550165</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Karn E, Trivedi K, et al. . Procalcitonin as a predictive marker in COVID-19: a systematic review and meta-analysis. PLOS One. 2022;17(9):e0272840. doi: 10.1371/journal.pone.0272840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0272840</ArticleId><ArticleId IdType="pmc">PMC9462680</ArticleId><ArticleId IdType="pubmed">36084093</ArticleId></ArticleIdList></Reference><Reference><Citation>Semiz S. COVID19 biomarkers: what did we learn from systematic reviews? Front Cell Infect Microbiol. 2022;12:1038908. doi: 10.3389/fcimb.2022.1038908.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.1038908</ArticleId><ArticleId IdType="pmc">PMC9792992</ArticleId><ArticleId IdType="pubmed">36583110</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng N, Wu Z, Liu Z, et al. . sTREM-1 as a predictive biomarker for disease severity and prognosis in COVID-19 patients. J Inflamm Res. 2024;17:3879–3891. doi: 10.2147/JIR.S464789.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S464789</ArticleId><ArticleId IdType="pmc">PMC11192294</ArticleId><ArticleId IdType="pubmed">38911986</ArticleId></ArticleIdList></Reference><Reference><Citation>Dziedzic EA, Gasior JS, Tuzimek A, et al. . Blood count-derived inflammatory markers and acute complications of ischemic heart disease in elderly women. J Clin Med. 2023;12(4):1369. doi: 10.3390/jcm12041369.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12041369</ArticleId><ArticleId IdType="pmc">PMC9961980</ArticleId><ArticleId IdType="pubmed">36835905</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Dong K, Fang C, et al. . The predictive values of monocyte–lymphocyte ratio in postoperative acute kidney injury and prognosis of patients with Stanford type A aortic dissection. Front Immunol. 2023;14:1195421. doi: 10.3389/fimmu.2023.1195421.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1195421</ArticleId><ArticleId IdType="pmc">PMC10404983</ArticleId><ArticleId IdType="pubmed">37554321</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonacera A, Stancanelli B, Colaci M, et al. . Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases. Int J Mol Sci. 2022;23(7):3636.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8998851</ArticleId><ArticleId IdType="pubmed">35408994</ArticleId></ArticleIdList></Reference><Reference><Citation>Dziedzic EA, Gąsior JS, Tuzimek A, et al. . Investigation of the associations of novel inflammatory biomarkers—Systemic Inflammatory Index (SII) and Systemic Inflammatory Response Index (SIRI)—with the severity of coronary artery disease and acute coronary syndrome occurrence. Int J Mol Sci. 2022;23(17):9553. doi: 10.3390/ijms23179553.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23179553</ArticleId><ArticleId IdType="pmc">PMC9455822</ArticleId><ArticleId IdType="pubmed">36076952</ArticleId></ArticleIdList></Reference><Reference><Citation>Halmaciu I, Arbănași EM, Kaller R, et al. . Chest CT severity score and systemic inflammatory biomarkers as predictors of the need for invasive mechanical ventilation and of COVID-19 patients’ mortality. Diagnostics. 2022;12(9):2089.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9497509</ArticleId><ArticleId IdType="pubmed">36140490</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueda Y, Yokogawa N, Murata K, et al. . C-reactive protein and the neutrophil-to-lymphocyte ratio on admission predicting bacteraemia with COVID-19. Ann Med. 2023;55(2):2278618. doi: 10.1080/07853890.2023.2278618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2023.2278618</ArticleId><ArticleId IdType="pmc">PMC10653696</ArticleId><ArticleId IdType="pubmed">37939245</ArticleId></ArticleIdList></Reference><Reference><Citation>Chadaga K, Prabhu S, Bhat V, et al. . Artificial intelligence for diagnosis of mild-moderate COVID-19 using haematological markers. Ann Med. 2023;55(1):2233541. doi: 10.1080/07853890.2023.2233541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2023.2233541</ArticleId><ArticleId IdType="pmc">PMC10339777</ArticleId><ArticleId IdType="pubmed">37436038</ArticleId></ArticleIdList></Reference><Reference><Citation>Akkok B. The role of the systemic inflammatory index in determining the need for intensive care in COVID-19 pneumonia. Eurasian J Pulmonol. 2023;25(3):183–190. doi: 10.14744/ejp.2023.1207.</Citation><ArticleIdList><ArticleId IdType="doi">10.14744/ejp.2023.1207</ArticleId></ArticleIdList></Reference><Reference><Citation>Erdogan A, Can FE, Gönüllü H.. Evaluation of the prognostic role of NLR, LMR, PLR, and LCR ratio in COVID-19 patients. J Med Virol. 2021;93(9):5555–5559. doi: 10.1002/jmv.27097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27097</ArticleId><ArticleId IdType="pmc">PMC8242916</ArticleId><ArticleId IdType="pubmed">34019701</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavalaga-Zegarra HJ, Palomino-Gutierrez JJ, Ulloque-Badaracco JR, et al. . C-reactive protein-to-albumin ratio and clinical outcomes in COVID-19 patients: a systematic review and meta-analysis. Trop Med Infect Dis. 2022;7(8):186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9414550</ArticleId><ArticleId IdType="pubmed">36006278</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, Han Y, Wu J, et al. . During the omicron pandemic wave, the severe systemic inflammatory status of COVID-19 indicated a higher risk of in-hospital mortality and mediated the clinical efficacy of corticosteroids. Infect Drug Resist. 2023;16:7377–7387. doi: 10.2147/IDR.S432679.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S432679</ArticleId><ArticleId IdType="pmc">PMC10695125</ArticleId><ArticleId IdType="pubmed">38053579</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Li H, Song C, et al. . Early prediction of disease progression in patients with severe COVID-19 using C-reactive protein to albumin ratio. Dis Markers. 2021;2021:1–11. doi: 10.1155/2021/6304189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6304189</ArticleId><ArticleId IdType="pmc">PMC8664519</ArticleId><ArticleId IdType="pubmed">34900028</ArticleId></ArticleIdList></Reference><Reference><Citation>The General Office of National Health Commission &amp; the General Office of National Administration of Traditional Chinese Medicine . Diagnosis and treatment protocol for COVID-19 patients (tentative 9th version); 2022.  [cited 2022 Mar 20]. Available from: https://www.gov.cn/zhengce/zhengceku/2022-03/15/content_5679257.htm</Citation></Reference><Reference><Citation>Sun W, Luo Z, Jin J, et al. . The neutrophil/lymphocyte ratio could predict noninvasive mechanical ventilation failure in patients with acute exacerbation of chronic obstructive pulmonary disease: a retrospective observational study. Int J Chron Obstruct Pulmon Dis. 2021;16:2267–2277. doi: 10.2147/COPD.S320529.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/COPD.S320529</ArticleId><ArticleId IdType="pmc">PMC8353100</ArticleId><ArticleId IdType="pubmed">34385816</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Z, Zheng Y, Yang L, et al. . Neutrophil/lymphocyte ratio is helpful for predicting weaning failure: a prospective, observational cohort study. J Thorac Dis. 2018;10(9):5232–5245. doi: 10.21037/jtd.2018.08.68.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2018.08.68</ArticleId><ArticleId IdType="pmc">PMC6196202</ArticleId><ArticleId IdType="pubmed">30416770</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Eliot M, Koestler DC, et al. . Association of neutrophil-to-lymphocyte ratio with mortality and cardiovascular disease in the Jackson Heart Study and modification by the Duffy antigen variant. JAMA Cardiol. 2018;3(6):455–462. doi: 10.1001/jamacardio.2018.1042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2018.1042</ArticleId><ArticleId IdType="pmc">PMC6128503</ArticleId><ArticleId IdType="pubmed">29801037</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu K, Lou L, Ye J, et al. . Prognostic role of the neutrophil–lymphocyte ratio in renal cell carcinoma: a meta-analysis. BMJ Open. 2015;5(4):e006404. doi: 10.1136/bmjopen-2014-006404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2014-006404</ArticleId><ArticleId IdType="pmc">PMC4390726</ArticleId><ArticleId IdType="pubmed">25854964</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarraf KM, Belcher E, Raevsky E, et al. . Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2009;137(2):425–428. doi: 10.1016/j.jtcvs.2008.05.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2008.05.046</ArticleId><ArticleId IdType="pubmed">19185164</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Liu C, Mao Z, et al. . Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis. Crit Care. 2020;24(1):647.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7667659</ArticleId><ArticleId IdType="pubmed">33198786</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosidło JW, Wolszczak-Biedrzycka B, Matowicka-Karna J, et al. . Clinical significance and diagnostic utility of NLR, LMR, PLR and SII in the course of COVID-19: a literature review. J Inflamm Res. 2023;16:539–562. doi: 10.2147/JIR.S395331.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S395331</ArticleId><ArticleId IdType="pmc">PMC9930576</ArticleId><ArticleId IdType="pubmed">36818192</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S, Khanna P, Singh AK.. The impact of neutrophil–lymphocyte count ratio in COVID-19: a systematic review and meta-analysis. J Intensive Care Med. 2022;37(7):857–869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9160638</ArticleId><ArticleId IdType="pubmed">34672824</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulloque-Badaracco JR, Ivan Salas-Tello W, Al-Kassab-Cordova A, et al. . Prognostic value of neutrophil-to-lymphocyte ratio in COVID-19 patients: a systematic review and meta-analysis. Int J Clin Pract. 2021;75(11):e14596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9614707</ArticleId><ArticleId IdType="pubmed">34228867</ArticleId></ArticleIdList></Reference><Reference><Citation>Simadibrata DM, Calvin J, Wijaya AD, et al. . Neutrophil-to-lymphocyte ratio on admission to predict the severity and mortality of COVID-19 patients: a meta-analysis. Am J Emerg Med. 2021;42:60–69. doi: 10.1016/j.ajem.2021.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2021.01.006</ArticleId><ArticleId IdType="pmc">PMC7832118</ArticleId><ArticleId IdType="pubmed">33453617</ArticleId></ArticleIdList></Reference><Reference><Citation>Sejópoles MD, Souza-Silva JP, Silva-Santos C, et al. . Prognostic value of neutrophil and lymphocyte counts and neutrophil/lymphocyte ratio for predicting death in patients hospitalized for COVID-19. Heliyon. 2023;9(6):e16964. doi: 10.1016/j.heliyon.2023.e16964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e16964</ArticleId><ArticleId IdType="pmc">PMC10238120</ArticleId><ArticleId IdType="pubmed">37292322</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseninia S, Ghobadi H, Garjani K, et al. . Aggregate index of systemic inflammation (AISI) in admission as a reliable predictor of mortality in COPD patients with COVID-19. BMC Pulm Med. 2023;23(1):107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10063934</ArticleId><ArticleId IdType="pubmed">37003999</ArticleId></ArticleIdList></Reference><Reference><Citation>Haryati H, Wicaksono B, Syahadatina M.. Complete blood count derived inflammation indexes predict outcome in COVID-19 patients: a study in Indonesia. J Infect Dev Ctries. 2023;17(3):319–326. doi: 10.3855/jidc.16527.</Citation><ArticleIdList><ArticleId IdType="doi">10.3855/jidc.16527</ArticleId><ArticleId IdType="pubmed">37023436</ArticleId></ArticleIdList></Reference><Reference><Citation>Fors M, Ballaz S, Ramírez H, et al. . Sex-dependent performance of the neutrophil-to-lymphocyte, monocyte-to-lymphocyte, platelet-to-lymphocyte and mean platelet volume-to-platelet ratios in discriminating COVID-19 severity. Front Cardiovasc Med. 2022;9:822556.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9023889</ArticleId><ArticleId IdType="pubmed">35463770</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyit M, Avci E, Nar R, et al. . Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19. Am J Emerg Med. 2021;40:110–114. doi: 10.1016/j.ajem.2020.11.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.11.058</ArticleId><ArticleId IdType="pmc">PMC7719281</ArticleId><ArticleId IdType="pubmed">33309506</ArticleId></ArticleIdList></Reference><Reference><Citation>Farias JP, Silva P, Codes L, et al. . Leukocyte ratios are useful early predictors for adverse outcomes of COVID-19 infection. Rev Inst Med Trop Sao Paulo. 2022;64:e73. doi: 10.1590/S1678-9946202264073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1678-9946202264073</ArticleId><ArticleId IdType="pmc">PMC9673132</ArticleId><ArticleId IdType="pubmed">36383895</ArticleId></ArticleIdList></Reference><Reference><Citation>Chelariu AC, Coman AE, Lionte C, et al. . The value of early and follow-up elevated scores based on peripheral complete blood cell count for predicting adverse outcomes in COVID-19 patients. J Pers Med. 2022;12(12):2037.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9781715</ArticleId><ArticleId IdType="pubmed">36556258</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao J, Dai R, Du RC, et al. . Hematologic changes predict clinical outcome in recovered patients with COVID-19. Ann Hematol. 2021;100(3):675–689. doi: 10.1007/s00277-021-04426-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-021-04426-x</ArticleId><ArticleId IdType="pmc">PMC7848253</ArticleId><ArticleId IdType="pubmed">33523290</ArticleId></ArticleIdList></Reference><Reference><Citation>Acar E, Demir A, Yıldırım B, et al. . The role of hemogram parameters and C-reactive protein in predicting mortality in COVID-19 infection. Int J Clin Pract. 2021;75(7):e14256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250321</ArticleId><ArticleId IdType="pubmed">33887100</ArticleId></ArticleIdList></Reference><Reference><Citation>Abensur Vuillaume L, Lefebvre F, Benhamed A, et al. . Lymphocyte-to-C-reactive protein (LCR) ratio is not accurate to predict severity and mortality in patients with COVID-19 admitted to the ED. Int J Mol Sci. 2023;24(6):5996.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10051361</ArticleId><ArticleId IdType="pubmed">36983064</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagunas-Rangel FA. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. J Med Virol. 2020;92(10):1733–1734.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228336</ArticleId><ArticleId IdType="pubmed">32242950</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang D, Bian T, Shen Y, et al. . Association between admission systemic immune-inflammation index and mortality in critically ill patients with sepsis: a retrospective cohort study based on MIMIC-IV Database. Clin Exp Med. 2023;23(7):3641–3650.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10022570</ArticleId><ArticleId IdType="pubmed">36930382</ArticleId></ArticleIdList></Reference><Reference><Citation>Pricop M, Ancusa O, Talpos S, et al. . The predictive value of systemic immune-inflammation index and symptom severity score for sepsis and systemic inflammatory response syndrome in odontogenic infections. J Pers Med. 2022;12(12):2026.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9782876</ArticleId><ArticleId IdType="pubmed">36556246</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y, Liu L, Zhao S, et al. . Blood inflammatory biomarkers predict in-hospital pneumonia after endovascular treatment of aneurysm in patients with aneurysmal subarachnoid hemorrhage. Neurosurg Rev. 2023;46(1):171. doi: 10.1007/s10143-023-02082-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10143-023-02082-5</ArticleId><ArticleId IdType="pubmed">37436536</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang YW, Yin XS, Li ZP.. Association of the systemic immune-inflammation index (SII) and clinical outcomes in patients with stroke: a systematic review and meta-analysis. Front Immunol. 2022;13:1090305. doi: 10.3389/fimmu.2022.1090305.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1090305</ArticleId><ArticleId IdType="pmc">PMC9797819</ArticleId><ArticleId IdType="pubmed">36591305</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Gu L, Chen Y, et al. . Systemic immune-inflammation index is a promising non-invasive biomarker for predicting the survival of urinary system cancers: a systematic review and meta-analysis. Ann Med. 2021;53(1):1827–1838. doi: 10.1080/07853890.2021.1991591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2021.1991591</ArticleId><ArticleId IdType="pmc">PMC8519535</ArticleId><ArticleId IdType="pubmed">34647517</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes-Ruiz JM, Garcia-Hernandez O, Martinez-Mier G, et al. . The role of aspartate aminotransferase-to-lymphocyte ratio index (ALRI) in predicting mortality in SARS-CoV-2 infection. Microorganisms. 2023;11(12):2894.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10745537</ArticleId><ArticleId IdType="pubmed">38138038</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia W, Tan Y, Hu S, et al. . Predictive value of systemic immune-inflammation index and neutrophil-to-lymphocyte ratio in patients with severe COVID-19. Clin Appl Thromb Hemost. 2022;28:10760296221111391. doi: 10.1177/10760296221111391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10760296221111391</ArticleId><ArticleId IdType="pmc">PMC9247370</ArticleId><ArticleId IdType="pubmed">35765218</ArticleId></ArticleIdList></Reference><Reference><Citation>Moisa E, Corneci D, Negoita S, et al. . Dynamic changes of the neutrophil-to-lymphocyte ratio, systemic inflammation index, and derived neutrophil-to-lymphocyte ratio independently predict invasive mechanical ventilation need and death in critically ill COVID-19 patients. Biomedicines. 2021;9(11):1656.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8615772</ArticleId><ArticleId IdType="pubmed">34829883</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimi A, Shobeiri P, Kulasinghe A, et al. . Novel systemic inflammation markers to predict COVID-19 prognosis. Front Immunol. 2021;12:741061. doi: 10.3389/fimmu.2021.741061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.741061</ArticleId><ArticleId IdType="pmc">PMC8569430</ArticleId><ArticleId IdType="pubmed">34745112</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocos R, Mahler B, Turcu-Stiolica A, et al. . Risk of death in comorbidity subgroups of hospitalized COVID-19 patients inferred by routine laboratory markers of systemic inflammation on admission: a retrospective study. Viruses. 2022;14(6):1201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9228480</ArticleId><ArticleId IdType="pubmed">35746672</ArticleId></ArticleIdList></Reference><Reference><Citation>Velazquez S, Madurga R, Castellano JM, et al. . Hemogram-derived ratios as prognostic markers of ICU admission in COVID-19. BMC Emerg Med. 2021;21(1):89. doi: 10.1186/s12873-021-00480-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12873-021-00480-w</ArticleId><ArticleId IdType="pmc">PMC8314257</ArticleId><ArticleId IdType="pubmed">34315437</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhammad S, Fischer I, Naderi S, et al. . Systemic inflammatory index is a novel predictor of intubation requirement and mortality after SARS-CoV-2 infection. Pathogens. 2021;10(1):58. doi: 10.3390/pathogens10010058.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10010058</ArticleId><ArticleId IdType="pmc">PMC7827801</ArticleId><ArticleId IdType="pubmed">33440649</ArticleId></ArticleIdList></Reference><Reference><Citation>López-Escobar A, Madurga R, Castellano JM, et al. . Hemogram as marker of in-hospital mortality in COVID-19. J Investig Med. 2021;69(5):962–969. doi: 10.1136/jim-2021-001810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-001810</ArticleId><ArticleId IdType="pubmed">33849952</ArticleId></ArticleIdList></Reference><Reference><Citation>Fois AG, Paliogiannis P, Scano V, et al. . The systemic inflammation index on admission predicts in-hospital mortality in COVID-19 patients. Molecules. 2020;25(23):5725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7731255</ArticleId><ArticleId IdType="pubmed">33291581</ArticleId></ArticleIdList></Reference><Reference><Citation>Funamizu N, Sogabe K, Shine M, et al. . Association between the preoperative C-reactive protein-to-albumin ratio and the risk for postoperative pancreatic fistula following distal pancreatectomy for pancreatic cancer. Nutrients. 2022;14(24):14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9783157</ArticleId><ArticleId IdType="pubmed">36558435</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Wang Y, Liao L, et al. . The relationship between C-reactive protein/albumin ratio and mortality in hypertensive patients: a national cohort study. Nutr Metab Cardiovasc Dis. 2024;34(7):1601–1609. doi: 10.1016/j.numecd.2024.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2024.02.011</ArticleId><ArticleId IdType="pubmed">38519295</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi W, Jiang Y, Tian H, et al. . C-reactive protein-to-albumin ratio (CAR) and C-reactive protein-to-lymphocyte ratio (CLR) are valuable inflammatory biomarker combination for the accurate prediction of periprosthetic joint infection. Infect Drug Resist. 2023;16:477–486. doi: 10.2147/IDR.S398958.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S398958</ArticleId><ArticleId IdType="pmc">PMC9884435</ArticleId><ArticleId IdType="pubmed">36721632</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunutsor SK, Kurl S, Voutilainen A, et al. . Serum C-reactive protein-to-albumin ratio may be a potential risk indicator for venous thromboembolism: findings from a prospective cohort study. Nutr Metab Cardiovasc Dis. 2023;33(4):864–867.</Citation><ArticleIdList><ArticleId IdType="pubmed">36740560</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathore SS, Oberoi S, Iqbal K, et al. . Prognostic value of novel serum biomarkers, including C-reactive protein to albumin ratio and fibrinogen to albumin ratio, in COVID-19 disease: a meta-analysis. Rev Med Virol. 2022;32(6):e2390. doi: 10.1002/rmv.2390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2390</ArticleId><ArticleId IdType="pmc">PMC9538909</ArticleId><ArticleId IdType="pubmed">36029484</ArticleId></ArticleIdList></Reference><Reference><Citation>Ak R, Doğanay F, Yilmaz E.. Comparison of C-reactive protein and C-reactive protein-to-albumin ratio in predicting mortality among geriatric coronavirus disease 2019 patients. Rev Assoc Med Bras (1992). 2022;68(1):82–86. doi: 10.1590/1806-9282.20210811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1806-9282.20210811</ArticleId><ArticleId IdType="pubmed">34909968</ArticleId></ArticleIdList></Reference><Reference><Citation>Karakoyun I, Colak A, Turken M, et al. . Diagnostic utility of C-reactive protein to albumin ratio as an early warning sign in hospitalized severe COVID-19 patients. Int Immunopharmacol. 2021;91:107285. doi: 10.1016/j.intimp.2020.107285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.107285</ArticleId><ArticleId IdType="pmc">PMC7833970</ArticleId><ArticleId IdType="pubmed">33348293</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley J, Sbaih N, Chandler TR, et al. . Pneumonia severity index and CURB-65 score are good predictors of mortality in hospitalized patients with SARS-CoV-2 community-acquired pneumonia. Chest. 2022;161(4):927–936.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8562015</ArticleId><ArticleId IdType="pubmed">34740594</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W, Liang H, Ou L, et al. . Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern Med. 2020;180(8):1081–1089.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7218676</ArticleId><ArticleId IdType="pubmed">32396163</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight SR, Ho A, Pius R, et al. . Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020;370:m3339. doi: 10.1136/bmj.m3339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3339</ArticleId><ArticleId IdType="pmc">PMC7116472</ArticleId><ArticleId IdType="pubmed">32907855</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, Geng N, Liu Z, et al. . Presepsin as a prognostic biomarker in COVID-19 patients: combining clinical scoring systems and laboratory inflammatory markers for outcome prediction. Virol J. 2024;21(1):96. doi: 10.1186/s12985-024-02367-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-024-02367-1</ArticleId><ArticleId IdType="pmc">PMC11046891</ArticleId><ArticleId IdType="pubmed">38671532</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>